Ligand Pharma (LGND) Tops Q3 EPS by 5c; Guides Q4, FY14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 318.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $318.78 | 52 Week High | $139.79 | |||
| Open | $318.78 | 52 Week Low | $82.07 | |||
| Day High | $318.78 | P/E | 741.35 | |||
| Day Low | $318.78 | EPS | $0.43 | |||
| Volume | 1 | |||||
